DW Insights & Inquiries
The word “endorse” used to describe a patient’s symptoms or history has become so prevalent, the term has entered the dictionary. Although I will have to accept the lexicographer’s decision, I do not endorse it!
Imagine my (and perhaps yours as well) surprise to find ivermectin making headlines in our national news for the past few weeks as the newest unproven treatment for COVID-19 infection.
Despite the dramatic presentation of acute hemorrhagic edema of infancy, the majority of patients have an excellent prognosis. Differentiation from Henoch-Schönlein purpura will guide management.
HVLPD is Epstein-Barr virus-related displaying a spectrum of disease ranging from benign to life-threatening lymphoma. While ultraviolet-light may be involved in its pathogenesis, more research is required to shed light on this disorder.
The rule for direct pathology result release to patients took effect April 2021 and carries with it a complicated patient communication experiment.
There is at least a theoretical benefit in trying water softeners in atopic patients. An ongoing trial will help determine if water softening can prevent atopic dermatitis and the subsequent atopic march.
The goal of this website is to improve the practice of dermatology, while being stimulating, practical, thought-provoking, and enlightening. Perspectives on current dermatologic literature are offered that are meant to be used in the clinic.
Explore Dermatology World Insights and Inquiries clinical topics by practice focus, condition, and medical journal source.
All content solely developed by the American Academy of Dermatology
The American Academy of Dermatology gratefully acknowledges support from Incyte Dermatology.
